BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9566821)

  • 21. Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels.
    Persico M; Persico E; Suozzo R; Conte S; De Seta M; Coppola L; Palmentieri B; Sasso FC; Torella R
    Gastroenterology; 2000 Apr; 118(4):760-4. PubMed ID: 10734027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical, virological and histopathological changes in Danish blood donors with antibodies to hepatitis C virus.
    Grønbaek KE; Jensen OJ; Krarup HB; Dietrichson O
    Dan Med Bull; 1996 Apr; 43(2):186-8. PubMed ID: 8741210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How to distinguish normal liver from chronic hepatitis in anti-HCV positive individuals with normal alanine aminotransferase levels.
    Sookoian S; Castaño G; Frider B; Flichman D
    Medicina (B Aires); 2002; 62(3):226-30. PubMed ID: 12150004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver histology and progression of fibrosis in individuals with chronic hepatitis C and persistently normal ALT.
    Kyrlagkitsis I; Portmann B; Smith H; O'Grady J; Cramp ME
    Am J Gastroenterol; 2003 Jul; 98(7):1588-93. PubMed ID: 12873583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology, serological markers, and hepatic disease of anti-HCV ELISA-2-positive blood donors.
    Salmerón FJ; Palacios A; Pérez-Ruiz M; Torres C; Oyonarte S; Fernández-Montoya A; Ruiz-Extremera A
    Dig Dis Sci; 1996 Oct; 41(10):1933-8. PubMed ID: 8888703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum hepatitis C virus RNA levels and liver injury in volunteer blood donors.
    Yuki N; Hayashi N; Takehara T; Hagiwara H; Hiramatsu N; Naito M; Kawanishi Y; Katayama K; Kasahara A; Fusamoto H
    Am J Gastroenterol; 1994 Sep; 89(9):1462-6. PubMed ID: 8079920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uselessness of liver biopsy in patients with hepatitis C virus chronic infection and persistently normal aminotransferase levels.
    Pasquale G; Sagnelli E; Coppola N; Scarano F; Scolastico C; Sagnelli C; Bellomo PF; Lettieri A; Filippini P; Piccinino F
    Infez Med; 2003 Mar; 11(1):11-7. PubMed ID: 12719665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase.
    Sánchez-Conde M; Berenguer J; Miralles P; Alvarez F; Carlos Lopez J; Cosin J; Pilar C; Ramirez M; Gutierrez I; Alvarez E
    Clin Infect Dis; 2006 Sep; 43(5):640-4. PubMed ID: 16886160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic hepatitis C with normal or abnormal aminotransferase levels: is it the same entity?
    Hervé S; Savoye G; Riachi G; Hellot MF; Goria O; Lerebours E; Colin R; Ducrotte P
    Eur J Gastroenterol Hepatol; 2001 May; 13(5):495-500. PubMed ID: 11396527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].
    Kusendová K; Gavorník P; Sabaka P; Sviteková K
    Vnitr Lek; 2016 Jan; 62(1):9-16. PubMed ID: 26967232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic hepatitis C in patients with normal or near normal alanine aminotransferase levels: the role of interferon alpha 2b therapy.
    Van Thiel DH; Caraceni P; Molloy PJ; Hassanein T; Kania RJ; Gurakar A; Friedlander L
    J Hepatol; 1995 Nov; 23(5):503-8. PubMed ID: 8583136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
    Hsieh MY; Dai CY; Lee LP; Huang JF; Tsai WC; Hou NJ; Lin ZY; Chen SC; Wang LY; Chang WY; Chuang WL; Yu ML
    J Clin Pathol; 2008 Mar; 61(3):333-7. PubMed ID: 17545561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation.
    Sterling RK; Sanyal AJ; Luketic VA; Stravitz RT; King AL; Post AB; Mills AS; Contos MJ; Shiffman ML
    Am J Gastroenterol; 1999 Dec; 94(12):3576-82. PubMed ID: 10606322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment.
    Mamori S; Suzuki F; Hosaka T; Akuta N; Someya T; Kobayashi M; Tsubota A; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kumada H
    J Gastroenterol; 2004 Aug; 39(8):776-82. PubMed ID: 15338372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. End-stage renal disease and hepatitis C infection: comparison of alanine aminotransferase levels and liver histology in patients with and without renal damage.
    Contreras AM; Ruiz I; Polanco-Cruz G; Monteón FJ; Celis A; Vázquez G; Gómez-Herrera E; García-Correa JE; Male-Velázquez R; Ruelas-Hernández S
    Ann Hepatol; 2007; 6(1):48-54. PubMed ID: 17297429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Virological characterization and liver histology in HCV positive subjects with normal and elevated ALT levels.
    Rossini A; Ravaggi A; Agostinelli E; Bercich L; Gazzola GB; Radaeli E; Callea F; Cariani E
    Liver; 1997 Jun; 17(3):133-8. PubMed ID: 9249727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver histology in anti-HCV-positive persons with normal or minimally elevated aminotransferases.
    Morales TG; Sampliner RE; Bhattacharyya A; Alter MJ
    J Clin Gastroenterol; 1995 Dec; 21(4):301-5. PubMed ID: 8583105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiological, biological and histological characterization of patients with indeterminate third-generation recombinant immunoblot assay antibody results for hepatitis C virus.
    Ríos M; Diago M; Rivera P; Tuset C; Cors R; García V; Carbonel P; Gonzalez C
    J Viral Hepat; 2006 Mar; 13(3):177-81. PubMed ID: 16475993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue expression of the hepatitis C virus NS3 protein does not correlate with histological or clinical features in patients with chronic hepatitis C.
    Liao WH; Tung SY; Shen CH; Lee KF; Wu CS
    Chang Gung Med J; 2011; 34(3):260-7. PubMed ID: 21733355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.